Related Experiment Video
Updated: Aug 2, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
Published on: October 14, 2016
Very long survival in pediatric cancer between 1944 and 1993
G Zhao1, C D Boysen, E F Brown
1Henan Institute of Medical Sciences, Henan Medical University, Henan 450052, China.
Insights
Pediatric cancer survival has significantly improved over four decades, with early diagnosis and later treatment eras leading to better outcomes. Patients surviving seven years post-diagnosis demonstrate excellent long-term survival rates.
Area of Science:
- Pediatric Oncology
- Cancer Epidemiology
- Survival Analysis
Background:
- Childhood and adolescent cancers present unique challenges in diagnosis and treatment.
- Long-term survival in pediatric oncology is a critical indicator of treatment efficacy and evolving medical advancements.
Purpose of the Study:
- To investigate factors associated with very long-term survival in pediatric cancer patients.
- To analyze survival trends across different diagnostic categories and treatment eras.
Main Methods:
- Retrospective analysis of 2750 pediatric cancer cases diagnosed between 1944 and 1983.
- Categorization of cancers into 11 diagnostic groups and four distinct treatment eras.
- Comparison of short-term (≤7 years) and long-term (>7 years) survival based on diagnostic and temporal factors.
Main Results:
- Leukemias, CNS tumors, and Hodgkin's disease were the most prevalent cancer types.
- Overall long-term survival rate was 41.7%, with significant increases observed from 18.7% in the earliest era to 52.6% in the latest.
- Prognosis improved with earlier stage diagnosis and in later treatment eras, with statistically significant survival gains across most categories.
Conclusions:
- Survival rates for pediatric and adolescent cancers have consistently improved over four consecutive eras.
- Early diagnosis and advancements in diagnostic techniques are strongly correlated with better survival outcomes.
- Pediatric cancer survivors often require long-term medical follow-up, highlighting the importance of sustained care beyond initial treatment.
Objective:
To identify factors associated with very long survival among all cancer cases diagnosed at age 19 years or younger registered by the Cancer Data Service at the University of Kansas Medical Center in Kansas City, Kansas, U.S.A. in the 40-year period between 1944 and 1983, with follow-up to 1993.
Methods:
There were 2720 pediatric patients with 2750 cancers who were studied. Forty-four types of cancer were grouped into 11 diagnostic categories. Diagnosis years spanned four eras: 1944-1953, 1954-1963, 1964-1973, and 1974-1983. Cases were compared using specific characteristics and were divided into short-term and long-term survivors with the division generously set at seven years. The proportions of the long-term survivors were compared by specific characteristics.
Results:
Among the diagnostic categories, leukemias were the most common (29.8%), followed by CNS tumors (15.2%), and Hodgkin's disease (9.0%). Male to female ratio was 4:3; average age at diagnosis was 8.83 +/- 6.08 years. Long-term survivors totaled 1148 (41.7%). Prognosis was better in cases diagnosed in earlier stages and in later eras. Proportion of long-term survivors increased from 18.7% in era I to 52.6% in era IV. Improvement of survival was statistically significant in most diagnostic categories.
Conclusions:
This study shows continuing improvement of survival during four consecutive eras for childhood and adolescent cancer. Early diagnosis was associated with better survival. Unstaged cases decreased over time reflecting progress in diagnostic techniques. Many patients died before seven years after diagnosis. Those who survived more than seven years had excellent survival. Pediatricians can expect to participate in the care of these patients long after the original dianosis and treatment.
Related Concept Videos
Longitudinal Research
Treatment Resistant Cancers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Comparing the Survival Analysis of Two or More Groups
Cancer Survival Analysis

